In a stunning reversal, the Commonwealth Director of Public Prosecution has dropped all criminal cartel charges against two investment banks and four individuals in relation to a $2.5 billion ANZ share placement, four years after the charges were brought following an allegedly questionable investigation by the ACCC.
Macpherson Kelley will head to an eleventh-hour mediation in a negligence case over the execution of a 10-year service station lease agreement with Shell, after the court heard settlement talks were well progressed.
Bristol-Myers Squibb has agreed to open up its subsidised treatment program for stage IV melanoma patients to individuals who have been treated with drugs made by its competitors to settle a misuse of market power lawsuit brought by rival Merck Sharpe & Dohme.
The parties in a class action accusing a Commonwealth Bank of Australia unit of breaching its superannuation trustee duties want the matter to be heard in person and are willing to foot the bill for the judge to travel to Sydney to make it happen.
Australian Mercedes-Benz dealers behind a $650 million lawsuit over the car maker’s decision to move to a fixed-price agency model allege the car maker engaged Deloitte as a consultant so it could “spin” its real reasons for making the change.
Google has failed in its bid to stay a competition lawsuit brought by Epic Games, after failing to show that the Fortnite game maker would not be disadvantaged if the case were heard in California instead.
Salter Brothers’ multmillion dollar investment in advisory firm Hendry Group is worthless, a court has been told in the fund manager’s case alleging it was the victim of miseleading representations.
An appeals court has dismissed a second attempt by Meta and Instagram to shut down a misuse of market power case by a Melbourne-based social media startup.
The directors of two money transfer businesses will be the first individuals to be sentenced for criminal cartel offences after pleading guilty Thursday to charges over the fixing of foreign exchange rates.
Consumer goods giant Reckitt-Benckiser is seeking special leave from the High Court to challenge a Full Court judgment that overturned a finding that AFT Pharmaceuticals ads’ for its painkiller Maxigesic were misleading.